Professor David Marais graduated from the
University of Cape Town and Groote Schuur
Hospital where much research was done on
familial hypercholesterolaemia at the time,
including work by Professors Mike Berger and
Wieland Gevers. After specialising in Internal
Medicine in 1984, he studied Medical
Biochemistry before returning to clinical
practice in 1989 to head the lipid clinic and to
develope a diagnostic and research laboratory
for severe dyslipidaemias. He participated in
pharmaceutical studies of new plasma
lipopoprotein modifying drugs. Having moved
to chemical pathology to focus more on
laboratory investigation, he remains dedicated
to ensure that severe metabolic errors can be
diagnosed for best management, including
innovating laboratory investigations when not
available. He has collaborated in research and
teaching in Australia, the Netherlands and the
United Kingdom, along with other centres in
South Africa.
Professor David Marais graduated from the
University of Cape Town and Groote Schuur
Hospital where much research was done on
familial hypercholesterolaemia at the time,
including work by Professors Mike Berger and
Wieland Gevers. After specialising in Internal
Medicine in 1984, he studied Medical
Biochemistry before returning to clinical
practice in 1989 to head the lipid clinic and to
develope a diagnostic and research laboratory
for severe dyslipidaemias. He participated in
pharmaceutical studies of new plasma
lipopoprotein modifying drugs. Having moved
to chemical pathology to focus more on
laboratory investigation, he remains dedicated
to ensure that severe metabolic errors can be
diagnosed for best management, including
innovating laboratory investigations when not
available. He has collaborated in research and
teaching in Australia, the Netherlands and the
United Kingdom, along with other centres in
South Africa.